1
Partners' positive and negative affect were measured at baseline and six-week follow-up.
2
Physiological outcomes are measured at baseline and after six and 24 months.
3
Neurobehavioral deficits were measured at baseline and day 3 after ischemic stroke.
4
BMD was measured at baseline and thereafter annually using dual-energy X-ray absorptiometry.
5
Complement factor C3c as marker for subclinical inflammation was measured at baseline.
6
UNGAL was measured at baseline, three-month follow-up, and after complete induction therapy.
7
IL-6 and CRP concentrations were measured at baseline from fasting blood samples.
8
Main outcome measures : Time to ascend and descend 3 steps measured at baseline.
9
Morning serum cortisol was measured at baseline and at week 12.
10
Body weight was measured at baseline and 24 months after baseline.
11
Serum levels of VICM were measured at baseline and multiple time points post-treatment.
12
Self-reported weight and motivation were measured at baseline and 8 weeks.
13
Carotid intima-media thickness was measured at baseline and at month 18.
14
In addition to hs-cTnT, plasma amino-terminal pro-B-type natriuretic peptide was measured at baseline.
15
Cognitive function and psychological symptoms were measured at baseline and post-intervention.
16
Serum calcium was measured at baseline and corrected for serum albumin.